Incompatibility of the circadian protein BMAL1 and HNF4α in hepatocellular carcinoma

Hepatocyte nuclear factor 4 alpha (HNF4α) is a master regulator of liver-specific gene expression with potent tumor suppressor activity, yet many liver tumors express HNF4α. This study reveals that P1-HNF4α, the predominant isoform expressed in the adult liver, inhibits expression of tumor promoting genes in a circadian manner. In contrast, an additional isoform of HNF4α, driven by an alternative promoter (P2-HNF4α), is induced in HNF4α-positive human hepatocellular carcinoma (HCC). P2-HNF4α represses the circadian clock gene ARNTL (BMAL1), which is robustly expressed in healthy hepatocytes, and causes nuclear to cytoplasmic re-localization of P1-HNF4α. We reveal mechanisms underlying the incompatibility of BMAL1 and P2-HNF4α in HCC, and demonstrate that forced expression of BMAL1 in HNF4α-positive HCC prevents the growth of tumors in vivo. These data suggest that manipulation of the circadian clock in HNF4α-positive HCC could be a tractable strategy to inhibit tumor growth and progression in the liver. Hepatocyte nuclear factor 4 alpha (HNF4α) is regulated by different promoters to generate two isoforms, one of which functions as a tumor suppressor. Here, the authors reveal that induction of the alternative isoform in hepatocellular carcinoma inhibits the circadian clock by repressing BMAL1, and the reintroduction of BMAL1 prevents HCC tumor growth.

• Publication year

  2018

• Venue

  Nature Communications

• Publication date

  2018-10-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41467-018-06648-6PMID 30341289PMCID 6195513
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of Hepatocyte Nuclear Factor 4 alpha (HNF4 α ) in Cell Proliferation and Cancer

  2018cited by this paper
• Increased expression of hepatocyte nuclear factor 4 alpha transcribed by promoter 2 indicates a poor prognosis in hepatocellular carcinoma

  2017cited by this paper
• New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategies.

  2017cited by this paper
• An HDAC3-PROX1 corepressor module acts on HNF4α to control hepatic triglycerides

  2017cited by this paper
• A PERK-miR211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survival

  2017cited by this paper
• Circadian Clock Gene Bmal1 Inhibits Tumorigenesis and Increases Paclitaxel Sensitivity in Tongue Squamous Cell Carcinoma.

  2017cited by this paper
• Transcriptional architecture of the mammalian circadian clock

  2016cited by this paper
• The Drosophila HNF4 nuclear receptor promotes glucose-stimulated insulin secretion and mitochondrial function in adults

  2016cited by this paper
• The Circadian Clock and Human Health.

  2016cited by this paper
• The genetic heterogeneity of hepatocellular carcinoma and the implications for personalised medicine

  2016cited by this paper
• Hepatocellular carcinoma: Where are we?

  2016cited by this paper
• Opposing roles of nuclear receptor HNF4α isoforms in colitis and colitis-associated colon cancer

  2016cited by this paper
• The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment

  2016cited by this paper
• The Small Molecule Nobiletin Targets the Molecular Oscillator to Enhance Circadian Rhythms and Protect against Metabolic Syndrome.

  2016cited by this paper
• Emerging roles of FGF signaling in hepatocellular carcinoma.

  2016cited by this paper
• Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.

  2016cited by this paper
• The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway.

  2016cited by this paper
• Circadian Rhythm Disruption Promotes Lung Tumorigenesis.

  2016cited by this paper
• Clock gene Per2 as a controller of liver carcinogenesis

  2016cited by this paper
• Pigment Epithelium-Derived Factor (PEDF) Inhibits Wnt/β-catenin Signaling in the Liver

  2015cited by this paper
• Differential Effects of Hepatocyte Nuclear Factor 4α Isoforms on Tumor Growth and T-Cell Factor 4/AP-1 Interactions in Human Colorectal Cancer Cells

  2015cited by this paper
• Leading Edge Review Time for Food : The Intimate Interplay between Nutrition , Metabolism , and the Circadian Clock

  2015cited by this paper
• MYC Disrupts the Circadian Clock and Metabolism in Cancer Cells.

  2015cited by this paper
• Role of hepatocyte nuclear factor 4α (HNF4α) in cell proliferation and cancer.

  2015cited by this paper
• Epigenetic control of EMT/MET dynamics: HNF4α impacts DNMT3s through miRs-29.

  2015cited by this paper
• Hepatocyte nuclear factor 4 alpha promotes the invasion, metastasis and angiogenesis of neuroblastoma cells via targeting matrix metalloproteinase 14.

  2015cited by this paper
• Molecular architecture of the mammalian circadian clock.

  2014cited by this paper
• Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors

  2014cited by this paper
• Universal Real-Time PCR-Based Assay for Lentiviral Titration

  2014cited by this paper
• Regulation of the tumor suppressor homeogene Cdx2 by HNF4α in intestinal cancer

  2013cited by this paper
• Erratum: An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis (Cell (2011) 151 (1233-1247))

  2013cited by this paper
• Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine‐induced hepatocellular carcinoma in rodents

  2013cited by this paper
• Reprogramming of the circadian clock by nutritional challenge.

  2013cited by this paper
• Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.

  2012cited by this paper
• Obesity, inflammation, and liver cancer.

  2012cited by this paper
• Src tyrosine kinase phosphorylation of nuclear receptor HNF4α correlates with isoform-specific loss of HNF4α in human colon cancer

  2012cited by this paper
• Suppression of Hepatocyte Proliferation by Hepatocyte Nuclear Factor 4α in Adult Mice*

  2012cited by this paper
• Matrigel-embedded 3D culture of Huh-7 cells as a hepatocyte-like polarized system to study hepatitis C virus cycle.

  2012cited by this paper
• A simple hanging drop cell culture protocol for generation of 3D spheroids.

  2011cited by this paper
• Hepatocyte Nuclear Factor 4 (cid:1) Coordinates a Transcription Factor Network Regulating Hepatic Fatty Acid Metabolism (cid:1)

  2010cited by this paper
• JTK_CYCLE: An Efficient Nonparametric Algorithm for Detecting Rhythmic Components in Genome-Scale Data Sets

  2010cited by this paper
• Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma.

  2010cited by this paper
• HNF4α--role in drug metabolism and potential drug target?

  2010cited by this paper
• Circadian Integration of Metabolism and Energetics

  2010cited by this paper
• Circadian disruption accelerates liver carcinogenesis in mice.

  2009cited by this paper
• Hepatocyte Nuclear Factor 4α Coordinates a Transcription Factor Network Regulating Hepatic Fatty Acid Metabolism

  2009cited by this paper
• Hep G2 is a hepatoblastoma-derived cell line.

  2009cited by this paper
• Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm

  2009cited by this paper
• Identification of an Endogenous Ligand Bound to a Native Orphan Nuclear Receptor

  2009cited by this paper
• Phosphorylation of a conserved serine in the deoxyribonucleic acid binding domain of nuclear receptors alters intracellular localization.

  2007cited by this paper
• Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production

  2007cited by this paper
• Glucocorticoid signaling synchronizes the liver circadian transcriptome

  2007cited by this paper
• Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors.

  2007cited by this paper
• Dysregulated expression of P1 and P2 promoter‐driven hepatocyte nuclear factor‐4α in the pathogenesis of human cancer

  2006cited by this paper
• Hepatocyte nuclear factor 4 (cid:1) orchestrates expression of cell adhesion proteins during the epithelial transformation of the developing liver

  2006cited by this paper
• In vivo role of the HNF4alpha AF-1 activation domain revealed by exon swapping.

  2006cited by this paper
• In vivo role of the HNF4α AF‐1 activation domain revealed by exon swapping

  2006cited by this paper
• Expression of the α7 Isoform of Hepatocyte Nuclear Factor (HNF) 4 Is Activated by HNF6/OC-2 and HNF1 and Repressed by HNF4α1 in the Liver*[boxs]

  2004cited by this paper
• Antiangiogenic property of pigment epithelium‐derived factor in hepatocellular carcinoma

  2004cited by this paper
• Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors

  2004cited by this paper
• Comparison of protein expression patterns between hepatocellular carcinoma cell lines and a hepatoblastoma cell line

  2004cited by this paper
• Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis.

  2003cited by this paper
• Regulation of hepatic fasting response by PPARγ coactivator-1α (PGC-1): Requirement for hepatocyte nuclear factor 4α in gluconeogenesis

  2003cited by this paper
• The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo.

  2002cited by this paper
• Competitive Cofactor Recruitment by Orphan Receptor Hepatocyte Nuclear Factor 4α1: Modulation by the F Domain

  2002cited by this paper
• Host circadian clock as a control point in tumor progression.

  2002cited by this paper
• Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice.

  2001cited by this paper
• Hepatocyte Nuclear Factor 4α (Nuclear Receptor 2A1) Is Essential for Maintenance of Hepatic Gene Expression and Lipid Homeostasis

  2001cited by this paper
• The bHLH gene Hes6, an inhibitor of Hes1, promotes neuronal differentiation.

  2000cited by this paper
• Acetylation regulates transcription factor activity at multiple levels.

  2000cited by this paper
• Mop3 is an essential component of the master circadian pacemaker in mammals.

  2000cited by this paper
• The Orphan Nuclear Receptor SHP Inhibits Hepatocyte Nuclear Factor 4 and Retinoid X Receptor Transactivation: Two Mechanisms for Repression

  2000cited by this paper
• Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4α

  1998cited by this paper
• Orphan receptor HNF-4 and bZip protein C/EBP alpha bind to overlapping regions of the apolipoprotein B gene promoter and synergistically activate transcription.

  1993cited by this paper
• Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily.

  1990cited by this paper

• Diurnal Regulation and Gene-Specific Vulnerability of Oxidative Alcohol-Metabolizing Enzymes to Circadian Disruption.

  2026cites this paper
• Comprehensive analysis and therapeutic implications of prognostic value of circadian rhythm genes in hepatocellular carcinoma

  2026cites this paper
• When Clocks Go Rogue: Circadian Rhythms and the Rise of Cancer

  2026cites this paper
• P2-HNF4α alters linoleic acid metabolism and mitigates soybean oil-induced obesity: role for oxylipins

  2025cites this paper
• Targeting the hepatic circadian clock concomitant with tyrosine kinase inhibition reverses late-stage hepatocellular carcinoma.

  2025cites this paper
• Genetics-nutrition interactions control diurnal enhancer-promoter dynamics and liver lipid metabolism.

  2025cites this paper
• Poor sleep and hepatic steatosis contribute to poorer quality of life in people with human immunodeficiency virus

  2025cites this paper
• Differential control of growth and identity by HNF4α isoforms in pancreatic ductal adenocarcinoma.

  2025cites this paper
• Nuclear p62/SQSTM1 facilitates ubiquitin-independent proteasomal degradation of BMAL1

  2025cites this paper
• Circadian rhythm in gastrointestinal cancer: clinical applications and future perspectives

  2025cites this paper
• Unravelling the link between circadian clock genes and brain tumors: From pathological disruptions to potential therapeutic interventions

  2025cites this paper
• The diverse roles of the circadian clock in cancer

  2025cites this paper
• AMPK activation prevents hepatocellular carcinoma development through inhibition of HNF4α activity

  2025cites this paper
• Balancing metabolism and regeneration in liver diseases through HNF4α targeting.

  2025cites this paper
• Differential control of growth and identity by HNF4α isoforms in pancreatic ductal adenocarcinoma

  2025cites this paper
• The molecular structure of secretory phospholipase A2 (sPLA2) and its clinical impact on hepatocellular carcinoma: Regulatory effect of PLA2G12B protein level.

  2025cites this paper
• Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics

  2025cites this paper
• Rhythm is essential: Unraveling the relation between the circadian clock and cancer.

  2025cites this paper
• Circadian disruption in hepatocellular carcinoma: Current findings and future directions of molecular mechanisms.

  2025cites this paper
• The contribution of circadian clock to the biological processes

  2024cites this paper
• The interplay between the PI3K/AKT pathway and circadian clock in physiologic and cancer‐related pathologic conditions

  2024cites this paper
• Extracellular Vesicles, Circadian Rhythms, and Cancer: A Comprehensive Review with Emphasis on Hepatocellular Carcinoma

  2024cites this paper
• Role of Hepatocyte Nuclear Factor 4 Alpha in Liver Cancer

  2024cites this paper
• Circadian control of tumor immunosuppression affects efficacy of immune checkpoint blockade

  2024cites this paper
• Major roles of the circadian clock in cancer

  2023cites this paper
• Dual Facets of Wnt/β-Catenin Signaling in Hepatocellular Carcinoma: Implications for Tumor Phenotyping and Clinical Management

  2023cites this paper
• Hepatocyte nuclear factor 4 a (HNF4α): A perspective in cancer.

  2023cites this paper
• Bioinformatic analysis of genetic changes CLOCK, BMAL1, CRY1, CRY2, PER1, PER2, PER3, and NPAS2 proteins in HCC patients

  2023cites this paper
• Determining subunit-subunit interaction from statistics of cryo-EM images: observation of nearest-neighbor coupling in a circadian clock protein complex

  2023cites this paper
• HNF4α isoforms: the fraternal twin master regulators of liver function

  2023cites this paper
• LncRNAs are involved in regulating ageing and age-related disease through the adenosine monophosphate-activated protein kinase signalling pathway

  2023cites this paper
• Circadian regulation of liver function: from molecular mechanisms to disease pathophysiology

  2023cites this paper
• HNF4α in Hepatocyte Health and Disease

  2023cites this paper
• Near-infrared fluorescence imaging of hepatocellular carcinoma cells regulated by β-catenin signaling pathway

  2023cites this paper
• Circadian clocks in health and disease: Dissecting the roles of the biological pacemaker in cancer

  2023cites this paper
• Circadian regulator BMAL1::CLOCK promotes cell proliferation in hepatocellular carcinoma by controlling apoptosis and cell cycle

  2023cites this paper
• Expression of p-STAT3 and c-Myc correlates with P2-HNF4α expression in nonalcoholic fatty liver disease (NAFLD)

  2022cites this paper
• Progressive loss of hepatocyte nuclear factor 4 alpha activity in chronic liver diseases in humans

  2022influential citation
• Clinical Significance of the Duality of Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma

  2022influential citation
• Long non-coding RNAs as the critical regulators of epithelial mesenchymal transition in colorectal tumor cells: an overview

  2022cites this paper
• The Circadian Clock and Cancer: Links between Circadian Disruption and Disease Pathology.

  2022cites this paper
• Hepatic PRMT1 ameliorates diet-induced hepatic steatosis via induction of PGC1α

  2022cites this paper
• A cooperative switch within the KaiC hexamer revealed by cryo-EM

  2022cites this paper
• Associations Between Abdominal Obesity Indices and Nonalcoholic Fatty Liver Disease: Chinese Visceral Adiposity Index

  2022cites this paper
• Single‐cell transcriptomic analysis reveals circadian rhythm disruption associated with poor prognosis and drug‐resistance in lung adenocarcinoma

  2022cites this paper
• ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancer

  2022cites this paper
• HNF4A modulates glucocorticoid action in the liver

  2022cites this paper
• Nutrients and the Circadian Clock: A Partnership Controlling Adipose Tissue Function and Health

  2022cites this paper
• Hepatitis B and circadian rhythm of the liver

  2022cites this paper
• Hepatic circadian and differentiation factors control liver susceptibility for fatty liver disease and tumorigenesis

  2022cites this paper
• Disruption of the circadian clock drives Apc loss of heterozygosity to accelerate colorectal cancer

  2022cites this paper
• Isobavachalcone Attenuates NLRP3 In ammasome-related Pyroptosis and Induces Apoptosis via Arresting Cell Cycle in Glioblastoma

  2022cites this paper
• Isobavachalcone’s Alleviation of Pyroptosis Contributes to Enhanced Apoptosis in Glioblastoma: Possible Involvement of NLRP3

  2022influential citation
• Conjugated Linoleic Acid Treatment Attenuates Cancerous features in Hepatocellular Carcinoma Cells

  2022cites this paper
• Down-regulation of BMAL1 by MiR-494-3p Promotes Hepatocellular Carcinoma Growth and Metastasis by Increasing GPAM-mediated Lipid Biosynthesis

  2022cites this paper
• SR9009 inhibits lethal prostate cancer subtype 1 by regulating the LXRα/FOXM1 pathway independently of REV-ERBs

  2022cites this paper
• Potential Role of the Circadian Clock in the Regulation of Cancer Stem Cells and Cancer Therapy

  2022cites this paper
• Overview on Common Genes Involved in the Onset of Glioma and on the Role of Migraine as Risk Factor: Predictive Biomarkers or Therapeutic Targets?

  2022cites this paper
• ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancer

  2022cites this paper
• Circadian Clock and Liver Cancer

  2021cites this paper
• Y-box binding protein 1 augments sorafenib resistance via the PI3K/Akt signaling pathway in hepatocellular carcinoma

  2021cites this paper
• Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)

  2021cites this paper
• Immunity Depletion, Telomere Imbalance, and Cancer-Associated Metabolism Pathway Aberrations in Intestinal Mucosa upon Short-Term Caloric Restriction

  2021cites this paper
• Protocol for whole-brain immunostaining of the turquoise killifish after tissue clearing

  2021cites this paper
• Mimicking Physiologically Relevant Hepatocyte Zonation Using Immunomodulatory Silk Liver Extracellular Matrix Scaffolds toward a Bioartificial Liver Platform.

  2021cites this paper
• Clocking cancer: the circadian clock as a target in cancer therapy

  2021cites this paper
• Immunity Depletion, Telomere Imbalance, and Cancer-associated Metabolism Pathway Aberrations in Intestinal Mucosa upon Caloric Restriction

  2021cites this paper
• Analysis of the HNF4A isoform-regulated transcriptome identifies CCL15 as a downstream target in gastric carcinogenesis

  2021cites this paper
• HNF4α isoforms regulate the circadian balance between carbohydrate and lipid metabolism in the liver

  2021cites this paper
• Cancer clocks in tumourigenesis: the p53 pathway and beyond.

  2021cites this paper
• Research on the circadian clock gene HNF4a in different malignant tumors

  2021cites this paper
• Roles of circadian clocks in cancer pathogenesis and treatment

  2021cites this paper
• HNF4A defines tissue-specific circadian rhythms by beaconing BMAL1::CLOCK chromatin binding and shaping the rhythmic chromatin landscape

  2021cites this paper
• Tuning up an aged clock: Circadian clock regulation in metabolism and aging

  2021cites this paper
• Understanding the significance of biological clock and its impact on cancer incidence.

  2021cites this paper
• Circadian Oscillation of Natural Antisense Transcripts Related to Human Core Clock Genes.

  2021cites this paper
• A TNFR2–hnRNPK Axis Promotes Primary Liver Cancer Development via Activation of YAP Signaling in Hepatic Progenitor Cells

  2021cites this paper
• LncRNA HOTAIR recruits SNAIL to inhibit the transcription of HNF4α and promote the viability, migration, invasion and EMT of colorectal cancer

  2021cites this paper
• Time-of-day specificity of anticancer drugs may be mediated by circadian regulation of the cell cycle

  2021cites this paper
• DeepHBV: a deep learning model to predict hepatitis B virus (HBV) integration sites

  2021cites this paper
• Hepatocyte Nuclear Factor 4 alpha 2 Messenger RNA Reprograms Liver‐Enriched Transcription Factors and Functional Proteins in End‐Stage Cirrhotic Human Hepatocytes

  2021cites this paper
• The Histone Variant MacroH2A1 Impacts Circadian Gene Expression and Cell Phenotype in an In Vitro Model of Hepatocellular Carcinoma

  2021cites this paper
• Metabolic rivalry: circadian homeostasis and tumorigenesis

  2020cites this paper
• A negative reciprocal regulatory axis between cyclin D1 and HNF4α modulates cell cycle progression and metabolism in the liver

  2020cites this paper
• Transcriptomically Revealed Oligo-Fucoidan Enhances the Immune System and Protects Hepatocytes via the ASGPR/STAT3/HNF4A Axis

  2020cites this paper
• Metabolic rivalry: circadian homeostasis and tumorigenesis

  2020cites this paper
• Downregulation of the Circadian Rhythm Regulator HLF Promotes Multiple-Organ Distant Metastases in Non-Small Cell Lung Cancer through PPAR/NF-κB Signaling.

  2020cites this paper
• Adipose Stromal Cell Expansion and Exhaustion: Mechanisms and Consequences

  2020cites this paper
• Melatonin and circadian rhythms in liver diseases: Functional roles and potential therapies

  2020cites this paper
• Liver gene regulatory networks: Contributing factors to nonalcoholic fatty liver disease

  2020cites this paper
• Data Mining ENCODE Data Predicts a Significant Role of SINA3 in Human Liver Cancer

  2020cites this paper
• Circadian Genes as Therapeutic Targets in Pancreatic Cancer

  2020cites this paper
• Liver-Specific Knockdown of Class IIa HDACs Has Limited Efficacy on Glucose Metabolism but Entails Severe Organ Side Effects in Mice

  2020cites this paper
• Alterations to the circadian clock make brain tumours vulnerable

  2019cites this paper
• Oxysterols and Gastrointestinal Cancers Around the Clock

  2019cites this paper
• Circadian Clocks and Cancer: Timekeeping Governs Cellular Metabolism.

  2019influential citation
• Long non-coding RNA LINC00858 exerts a tumor-promoting role in colon cancer via HNF4α and WNK2 regulation

  2019cites this paper
• A Role for the Biological Clock in Liver Cancer

  2019cites this paper
• LncRNA LINP1 regulates acute myeloid leukemia progression via HNF4α/AMPK/WNT5A signaling pathway

  2019cites this paper
• Clock genes and the role of melatonin in cancer cells: an overview

  2019cites this paper